Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
198.60 DKK | +2.00% | +2.43% | +4.57% |
01-15 | Gubra appoints Anne-Marie Levy Rasmussen as COO | FW |
01-15 | Gubra Appoints Anne-Marie Levy Rasmussen as Chief Operating Officer | CI |
Chart calendar Bavarian Nordic A/S
Upcoming events on Bavarian Nordic A/S
Past events on Bavarian Nordic A/S
2024-11-15 08:00 | Q3 2024 Earnings Call |
2024-11-15 01:38 | Q3 2024 Earnings Release |
2024-08-22 08:00 | Q2 2024 Earnings Call |
2024-08-22 01:45 | Q2 2024 Earnings Release |
2024-05-08 08:00 | Q1 2024 Earnings Call |
2024-05-08 01:37 | Q1 2024 Earnings Release |
2024-04-16 10:00 | Annual General Meeting |
2024-03-06 08:00 | Q4 2023 Earnings Call |
2024-03-03 | TD Cowen Health Care Conference |
2024-02-27 | Capital Market Day |
2024-02-26 | Capital Market Day |
2024-02-25 | Capital Market Day - Copenhagen |
2024-02-21 02:13 | Q4 2023 Earnings Release |
2023-11-16 08:00 | Q3 2023 Earnings Call |
2023-11-16 01:37 | Q3 2023 Earnings Release |
2023-11-14 07:00 | Jefferies London Healthcare Conference - Fireside Chat |
2023-08-31 00:00 | HC Andersen Capital Life Science Seminar |
2023-08-23 08:00 | Q2 2023 Earnings Call |
2023-08-23 01:35 | Q2 2023 Earnings Release |
2023-08-07 08:00 | CHIKV VLP Phase 3 Study Results Call |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 1 898 1 899 -0.08% | 3 151 3 149 0.07% | 7 062 6 966 1.38% | 5 511 | 6 784 | 5 583 |
EBITDA Million DKK | Released Forecast Spread | 74,8 71,9 4.03% | 328 329 -0.24% | 2 615 2 396 9.14% | 1 519 | 2 754 | 1 874 |
EBIT Million DKK | Released Forecast Spread | -313 -290 -7.97% | -70,8 -104 31.88% | 2 060 1 510 36.45% | 897 | 2 261 | 1 165 |
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | -454 -378 -20.24% | -332 -251 -31.91% | 1 483 1 321 12.24% | 888 | 2 118 | 1 259 |
Net income Million DKK | Released Forecast Spread | -465 -368 -26.4% | -347 -255 -36.47% | 1 475 1 228 20.08% | 798 | 1 693 | 982 |
EPS DKK | Released Forecast Spread | -7,40 -5,41 -36.79% | -4,90 -3,56 -37.74% | 19,2 16,1 19.4% | 9,87 | 20,9 | 12,1 |
Announcement Date | 04/03/22 | 02/03/23 | 06/03/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 1 252 1 453 -13.81% | 1 987 1 663 19.47% | 1 376 1 839 -25.16% | 2 447 2 313 5.81% | 831 1 108 -24.96% | 1 427 1 178 21.23% | 1 363 1 800 -24.26% | 1 869 |
EBITDA Million DKK | Released Forecast Spread | 481 394 22.15% | 690 468 47.33% | 380 593 -35.93% | 1 063 767 38.64% | 21,8 190 -88.51% | 420 147 186.37% | 250 500 -49.91% | 837 |
EBIT Million DKK | Released Forecast Spread | 370 309 19.83% | 546 523 4.41% | 232 491 -52.8% | 913 | 266 150 77.26% | 93,6 500 -81.29% | ||
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 376 260 44.8% | 543 313 73.36% | -335 480 -169.68% | 898 663 35.4% | -114 139 -182.41% | 266 33,0 706.03% | 72,5 348 -79.18% | 668 |
Net income Million DKK | Released Forecast Spread | 376 246 53.29% | 538 354 52.03% | -341 443 -176.88% | 901 521 72.91% | -114 109 -205.48% | 261 150 74.09% | 70,5 387 -81.76% | 608 |
EPS DKK | Released Forecast Spread | 5,10 2,38 114.29% | 7,10 9,87 -28.03% | -4,40 6,43 -168.43% | 11,7 7,50 56% | -1,50 2,00 -175% | 3,30 7,52 -56.12% | 0,90 13,3 -93.23% | 7,40 |
Announcement Date | 09/05/23 | 23/08/23 | 16/11/23 | 06/03/24 | 08/05/24 | 22/08/24 | 15/11/24 | - |
Past sector events for Bavarian Nordic A/S
Today | AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected) |
2025-01-10 07:00 | TILRAY BRANDS, INC.: Q2 2025 Earnings Release |
2025-01-10 04:09 | LOTUS PHARMACEUTICAL CO., LTD.: December 2024 Sales and Revenue Release |
2025-01-09 18:50 | BORA PHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
2025-01-09 05:25 | SCINOPHARM TAIWAN, LTD.: December 2024 Sales and Revenue Release |
2025-01-08 | HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release |
2025-01-08 03:17 | CALIWAY BIOPHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
2024-12-10 11:45 | MEDINCELL S.A.: Q2 2025 Earnings Release |
2024-12-10 04:02 | LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release |
2024-12-10 01:29 | CENTER LABORATORIES, INC.: November 2024 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BAVA Stock
- Calendar Bavarian Nordic A/S
MarketScreener is also available in this country: United States.
Switch edition